tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

NURPF Stock Latest News

Neuren Pharmaceuticals Reports Cessation of Securities
Company AnnouncementsNeuren Pharmaceuticals Reports Cessation of Securities
13h ago
Neuren Pharmaceuticals Reports 2024 Full-Year Results
PremiumCompany Announcements
Neuren Pharmaceuticals Reports 2024 Full-Year Results
4d ago
Neuren Pharmaceuticals Reports Strong 2024 Earnings
PremiumCompany Announcements
Neuren Pharmaceuticals Reports Strong 2024 Earnings
4d ago
Neuren Pharmaceuticals Achieves Major Sales Milestone with DAYBUE™
PremiumCompany Announcements
Neuren Pharmaceuticals Achieves Major Sales Milestone with DAYBUE™
4d ago
Neuren Pharmaceuticals Achieves Record Income and Expands Global Reach
PremiumCompany Announcements
Neuren Pharmaceuticals Achieves Record Income and Expands Global Reach
4d ago
Neuren Pharmaceuticals Reports Strong Comprehensive Income Amid Currency Changes
PremiumCompany AnnouncementsNeuren Pharmaceuticals Reports Strong Comprehensive Income Amid Currency Changes
4d ago
Neuren Pharmaceuticals to Announce 2024 Financial Results and Host Investor Webinar
Premium
Company Announcements
Neuren Pharmaceuticals to Announce 2024 Financial Results and Host Investor Webinar
5d ago
Neuren Pharmaceuticals Sees Robust Growth in DAYBUE Sales
Premium
Company Announcements
Neuren Pharmaceuticals Sees Robust Growth in DAYBUE Sales
5d ago
Vanguard Group Acquires Substantial Stake in Neuren Pharmaceuticals
PremiumCompany Announcements
Vanguard Group Acquires Substantial Stake in Neuren Pharmaceuticals
7d ago
Neuren Pharmaceuticals Receives FDA Fast Track Designation for NNZ-2591 in Pitt Hopkins Syndrome
PremiumCompany Announcements
Neuren Pharmaceuticals Receives FDA Fast Track Designation for NNZ-2591 in Pitt Hopkins Syndrome
13d ago
Neuren Pharmaceuticals Gains Financial Boost from Voucher Sale
PremiumCompany Announcements
Neuren Pharmaceuticals Gains Financial Boost from Voucher Sale
25d ago
Neuren Pharmaceuticals Secures FDA Type C Meeting for Phelan-McDermid Syndrome Trial
PremiumCompany Announcements
Neuren Pharmaceuticals Secures FDA Type C Meeting for Phelan-McDermid Syndrome Trial
25d ago
Neuren Pharmaceuticals to Present at 2025 Autism Research Meeting
PremiumCompany AnnouncementsNeuren Pharmaceuticals to Present at 2025 Autism Research Meeting
26d ago
Neuren Pharmaceuticals Advances Drug Development and Expands Market Reach
Premium
Company Announcements
Neuren Pharmaceuticals Advances Drug Development and Expands Market Reach
1M ago
Neuren Pharmaceuticals Focuses on Neurodevelopmental Advancements at J.P. Morgan Conference
Premium
Company Announcements
Neuren Pharmaceuticals Focuses on Neurodevelopmental Advancements at J.P. Morgan Conference
2M ago
Neuren’s Trofinetide Moves Closer to European Approval for Rett Syndrome
PremiumCompany Announcements
Neuren’s Trofinetide Moves Closer to European Approval for Rett Syndrome
2M ago
Neuren Pharmaceuticals Announces Share Buy-Back Program
PremiumCompany Announcements
Neuren Pharmaceuticals Announces Share Buy-Back Program
3M ago
Neuren Pharmaceuticals Boosts Buy-Back Program
PremiumCompany Announcements
Neuren Pharmaceuticals Boosts Buy-Back Program
3M ago
Neuren Pharmaceuticals Gains from Acadia’s $150M Voucher Sale
PremiumCompany Announcements
Neuren Pharmaceuticals Gains from Acadia’s $150M Voucher Sale
3M ago
Neuren Pharmaceuticals Updates on Share Buy-Back Program
PremiumCompany AnnouncementsNeuren Pharmaceuticals Updates on Share Buy-Back Program
3M ago
Neuren Pharmaceuticals’ Strategic Share Buy-Back Update
Premium
Company Announcements
Neuren Pharmaceuticals’ Strategic Share Buy-Back Update
3M ago
Neuren Pharmaceuticals Boosts Shareholder Value with Buy-Back
Premium
Company Announcements
Neuren Pharmaceuticals Boosts Shareholder Value with Buy-Back
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >